Chargement en cours...
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
The U.S. Food and Drug Administration recently marked 10 years since first updating the labeling for warfarin (often referred to as the “poster child” of pharmacogenomics) to include information regarding the potential impact of CYP2C9 and VKORC1 genetic variation on warfarin dosing requirements and...
Enregistré dans:
| Publié dans: | JACC Basic Transl Sci |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6115648/ https://ncbi.nlm.nih.gov/pubmed/30175278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2018.06.001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|